Bausch Health BHC · NYSE
$6.48 +0.39% (+$0.03)
Summary
60 / 100 · Bulios Score
What speaks for it
- It earns 20 USD a year on every 100 USD of invested capital.
- The share price is below the Bulios Fair Price.
- Out of every 100 USD of revenue, 13 USD is left as free cash.
What to watch
- The company made a loss over the last 12 months.
- Operating profit does not even cover the interest on its debt.
- It missed profit estimates 5 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 5.4% a year over 5 years. Over the last 3 years it grew by 8.7% a year.
Growth in detailDoes it make money?
Very wellOver the last 12 months it made a loss of $1.10B.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 14.9 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 19
- Hold 15
- Sell 4
Today's price within the analysts' price targets
The average target of $9.83 is 52% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 49%
- Pharmaceutical Products 23%
- Device Products 12%
- Over the Counter Products 9.8%
- Branded and Other Generic Products 4.7%
- Other 1.1%
By region
- United States and Puerto Rico 62%
- Other Countries 12%
- CHINA 5.0%
- CANADA 4.2%
- POLAND 3.8%
- Other 14%
Product brings in 49% of revenue. Device Products grew fastest, by 11% a year.
Segments in detail